Kcell Joint Stock Company (KASE:KCEL)
Kazakhstan · Delayed Price · Currency is KZT 3,423.90
+19.40 (0.57%)
At close: Aug 1, 2025
Regulus Therapeutics Cash Flow Statement
Financials in millions KZT. Fiscal year is January - December.
Millions KZT. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 8,560 | 10,159 | 32,897 | 40,350 | 32,506 | 17,578 | Upgrade |
Depreciation & Amortization | 32,234 | 29,171 | 22,130 | 18,993 | 20,157 | 19,792 | Upgrade |
Other Amortization | 21,638 | 22,024 | 22,344 | 11,461 | 10,621 | 11,010 | Upgrade |
Loss (Gain) From Sale of Assets | -60 | 205 | 558 | 25 | 1,134 | 273 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | 553 | 588 | 5,227 | Upgrade |
Provision & Write-off of Bad Debts | 2,739 | 3,156 | 5,702 | 6,264 | 2,106 | 1,547 | Upgrade |
Other Operating Activities | -3,209 | -263 | -8,456 | -477 | -203 | 3,094 | Upgrade |
Change in Accounts Receivable | -3,800 | 1,335 | -6,449 | -14,709 | -3,285 | -4,762 | Upgrade |
Change in Inventory | 32 | -612 | -2,389 | -2,350 | 2,601 | -3,272 | Upgrade |
Change in Accounts Payable | 9,349 | -5,932 | 51 | -4,584 | 5,645 | -1,708 | Upgrade |
Change in Unearned Revenue | -1,319 | -1,135 | 4,216 | 2,368 | 1,229 | -2,171 | Upgrade |
Change in Other Net Operating Assets | 16,091 | 21,112 | 9,633 | 8,034 | 957 | 5,651 | Upgrade |
Operating Cash Flow | 82,255 | 79,220 | 80,237 | 65,928 | 74,056 | 52,259 | Upgrade |
Operating Cash Flow Growth | 13.26% | -1.27% | 21.70% | -10.97% | 41.71% | 49.05% | Upgrade |
Capital Expenditures | -62,196 | -61,442 | -69,393 | -23,421 | -18,059 | -12,142 | Upgrade |
Sale of Property, Plant & Equipment | 39 | 87 | 130 | 25 | 96 | 161 | Upgrade |
Sale (Purchase) of Intangibles | -17,524 | -18,094 | -90,701 | -14,254 | -13,102 | -11,413 | Upgrade |
Investment in Securities | - | - | 14,813 | -14,813 | 18,613 | -13,227 | Upgrade |
Other Investing Activities | -2 | -2 | - | - | - | - | Upgrade |
Investing Cash Flow | -79,683 | -79,451 | -145,151 | -52,463 | -12,452 | -36,621 | Upgrade |
Long-Term Debt Issued | - | 167,177 | 110,761 | - | 62,500 | 27,000 | Upgrade |
Total Debt Issued | 144,238 | 167,177 | 110,761 | - | 62,500 | 27,000 | Upgrade |
Long-Term Debt Repaid | - | -169,534 | -80,109 | -18,370 | -78,575 | -19,888 | Upgrade |
Total Debt Repaid | -142,106 | -169,534 | -80,109 | -18,370 | -78,575 | -19,888 | Upgrade |
Net Debt Issued (Repaid) | 2,132 | -2,357 | 30,652 | -18,370 | -16,075 | 7,112 | Upgrade |
Common Dividends Paid | - | - | - | - | -17,578 | -9,000 | Upgrade |
Financing Cash Flow | 2,132 | -2,357 | 30,652 | -18,370 | -33,653 | -1,888 | Upgrade |
Foreign Exchange Rate Adjustments | 175 | 358 | -955 | -249 | 428 | 448 | Upgrade |
Net Cash Flow | 4,879 | -2,230 | -35,217 | -5,154 | 28,379 | 14,198 | Upgrade |
Free Cash Flow | 20,059 | 17,778 | 10,844 | 42,507 | 55,997 | 40,117 | Upgrade |
Free Cash Flow Growth | 3567.09% | 63.94% | -74.49% | -24.09% | 39.58% | 52.95% | Upgrade |
Free Cash Flow Margin | 8.45% | 7.55% | 4.85% | 19.41% | 28.85% | 22.96% | Upgrade |
Free Cash Flow Per Share | 100.30 | 88.89 | 54.22 | 212.53 | 279.99 | 200.59 | Upgrade |
Cash Interest Paid | 20,854 | 19,926 | 11,314 | 8,652 | 10,221 | 10,903 | Upgrade |
Cash Income Tax Paid | 4,220 | 5,600 | 13,852 | 12,902 | 7,609 | 7,378 | Upgrade |
Levered Free Cash Flow | -4,666 | -7,924 | -94,334 | 21,853 | 40,651 | 31,824 | Upgrade |
Unlevered Free Cash Flow | 9,120 | 5,441 | -86,626 | 27,423 | 46,857 | 39,034 | Upgrade |
Change in Net Working Capital | -17,987 | -15,926 | 856 | 1,932 | -14,611 | -5,092 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.